Bisphosphonates as a first-line treatment for glucocorticoid-induced osteoporosis: comment on the article by Saag et al

被引:1
|
作者
Gonzalez-Rodriguez, Elena [1 ]
Aubry-Rozier, Berengere [1 ]
Stoll, Delphine [1 ]
Lamy, Olivier [1 ]
机构
[1] Lausanne Univ Hosp, Lausanne, Switzerland
关键词
VERTEBRAL FRACTURES; DISCONTINUATION; DENOSUMAB;
D O I
10.1002/art.41016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1770 / 1771
页数:2
相关论文
共 50 条
  • [1] Where does denosumab stand in the treatment of glucocorticoid-induced osteoporosis? Comment on the article by Saag et al
    Chattopadhyay, Arghya
    Sharma, Shefali K.
    Sharma, Aman
    Jain, Sanjay
    Dhir, Varun
    ARTHRITIS & RHEUMATOLOGY, 2019, 71 (10) : 1770 - 1770
  • [2] Fracture risk in glucocorticoid-induced osteoporosis: comment on the article by Grossman et al
    Grossman, Jennifer M.
    Ranganath, Veena K.
    Chen, Weiling
    Furst, Daniel E.
    McMahon, Maureen
    Volkmann, Elizabeth
    Gordon, Rebecca
    Deal, Chad
    Caplan, Liron
    Curtis, Jeffrey R.
    Patkar, Nivedita M.
    Saag, Kenneth G.
    ARTHRITIS CARE & RESEARCH, 2012, 64 (01) : 157 - 158
  • [3] Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis
    Doga, M
    Bonadonna, S
    Burattin, A
    Carpinteri, R
    Manelli, F
    Giustina, A
    GLUCOCORTICOID-INDUCED OSTEOPOROSIS, 2002, 30 : 150 - 164
  • [4] Bisphosphonates in the prevention and treatment of glucocorticoid-induced osteoporosis
    Blair, MM
    Carson, DS
    Barrington, R
    JOURNAL OF FAMILY PRACTICE, 2000, 49 (09): : 839 - 848
  • [5] Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis: pros
    Rossini, Maurizio
    Orsolini, Giovanni
    Viapiana, Ombretta
    Adami, Silvano
    Gatti, Davide
    ENDOCRINE, 2015, 49 (03) : 620 - 627
  • [6] Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis: pros
    Maurizio Rossini
    Giovanni Orsolini
    Ombretta Viapiana
    Silvano Adami
    Davide Gatti
    Endocrine, 2015, 49 : 620 - 627
  • [7] Bisphosphonates in the prevention and treatment of glucocorticoid-induced osteoporosis
    Roux, C
    Dougados, M
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2000, 18 (05) : S49 - S52
  • [8] 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis: Comment on the Article by Buckley et al
    Maricic, Michael
    Deal, Chad
    Dore, Robin
    Laster, Andrew
    ARTHRITIS CARE & RESEARCH, 2018, 70 (06) : 949 - 950
  • [9] Current Treatment for Glucocorticoid-Induced Osteoporosis: Beyond Bisphosphonates
    Humphrey, Mary Beth
    CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2024, 10 (04) : 77 - 84
  • [10] Bisphosphonates, a new treatment for glucocorticoid-induced osteoporosis in children
    Noguera, A
    Ros, JB
    Pavía, C
    Alcover, E
    Valls, C
    Villaronga, M
    González, E
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2003, 16 (04): : 529 - 536